Patient-Derived In Vitro Models for Drug Discovery in Colorectal Carcinoma
Authors:
- George M. RamzyGRGeorge M. Ramzy
- Thibaud KoesslerTKThibaud Koessler
- Eloise DucreyEDEloise Ducrey
- Thomas McKeeTMThomas McKee
- Frédéric RisFRFrédéric Ris
- Nicolas BuchsNBNicolas Buchs
- Laura Rubbia-BrandtLRLaura Rubbia-Brandt
- Pierre-Yves DietrichPDPierre-Yves Dietrich
- Patrycja Nowak-SliwinskaPNPatrycja Nowak-Sliwinska
Open Access
Abstract
Lack of relevant preclinical models that reliably recapitulate the complexity and heterogeneity of human cancer has slowed down the development and approval of new anti-cancer therapies. Even though two-dimensional in vitro culture models remain widely used, they allow only partial cell-to-cell and cell-to-matrix interactions and therefore do not represent the complex nature of the tumor microenvironment. Therefore, better models reflecting intra-tumor heterogeneity need to be incorporated in the drug screening process to more reliably predict the efficacy of drug candidates. Classic methods of modelling colorectal carcinoma (CRC), while useful for many applications, carry numerous limitations. In this review, we address the recent advances in in vitro CRC model systems, ranging from conventional CRC patient-derived models, such as conditional reprogramming-based cell cultures, to more experimental and state-of-the-art models, such as cancer-on-chip platforms or liquid biopsy.Keywords
Funding Information
- European Research Council (680209)
This publication has 158 references indexed in Scilit:
- Circulating tumor cellsProceedings of the National Academy of Sciences, 2013
- Conditionally reprogrammed cells represent a stem-like state of adult epithelial cellsProceedings of the National Academy of Sciences, 2012
- Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trialThe Lancet Oncology, 2012
- Histological and Molecular Evaluation of Patient-Derived Colorectal Cancer ExplantsPLOS ONE, 2012
- A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomasBritish Journal of Cancer, 2011
- The APL Paradigm and the “Co-Clinical Trial” ProjectCancer Discovery, 2011
- Human keratinocytes are efficiently immortalized by a Rho kinase inhibitorJournal of Clinical Investigation, 2010
- Efficient Procurement of Epithelial Stem Cells from Human Tissue Specimens Using a Rho-Associated Protein Kinase Inhibitor Y-27632Tissue Engineering Part A, 2010
- Human colon tissue in organ culture: preservation of normal and neoplastic characteristicsIn Vitro Cellular & Developmental Biology - Animal, 2009
- Newly characterised ex vivo colospheres as a three-dimensional colon cancer cell model of tumour aggressivenessBritish Journal of Cancer, 2009